ArticleCancer research2010

Silencing of RON receptor signaling promotes apoptosis and gemcitabine sensitivity in pancreatic cancers.

Jocelyn Logan-Collins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.